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IN 1951, Bonser, Clayson and Jull published some of the results of a quanti-
tative study ofthe metabolism of2-naphthylamine by various species. An appa-
rent correlation was demonstrated between the proportion of a dose of 2-naph-
thylamine (I) excreted by way of the urine as 2-amino-1-naphthol derivatives (II)
and the biological response of the species to treatment with 2-naphthylamine.
Thus it was shown that the dog, which is particularly susceptible to 2-naph-
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thylamine carcinogenesis, excretes 55 to 70 per cent of a dose of 2-naph-
thylamine as 2-amino-1-naphthol conjugates, whereas the mouse, rat and
rabbit, which are less susceptible, excrete smaller quantities in this form. Quan-
titative studies also revealed that the concentration of 2-amino-l-naphthol deri-
vatives in the urine relative to the plasma was approximately 200:1 and from this
it was concluded that the exposure of the urinary tract epithelium to the meta-
bolite was very much greater than that of any other part of the body.
Evidence was also presented (Bonser et al., 1951) that synthetic 2-amino-1-
naphthol hydrochloride (III) was a carcinogen, using the method devised by Jull
(1951) of surgical introduction of paraffin wax pellets containing the chemical
into the lumen ofthe bladder ofthe mouse. Thepresent communication contains
the results of an extended series of experiments which were undertaken to test
the carcinogenic potency ofthe parent amine and ofits metabolite bythis method.
The results of other experiments previously conducted and designed to discover
a small experimental animal susceptible to bladder carcinogenesis by 2-naphthyl-
amine are also reviewed.
METHODS.
Experiment 1.
Surgical introduction ofwax pellets into the bladders of mice.
White mice obtained from a dealer were used. The standard pellet weighed
10 to 20 mg. and contained 10to 15per cent by weight ofthe suspected carcinogenCARCINOGENIC PROPERTIES OF 2-NAPHTHYLAMINE
in suspension in 56° or 80° melting-point paraffin wax (i.e., approximately 1 to 2
mg. of carcinogen per pellet). The technical procedures are described by Jull
(1951). It was found convenient to distendthe bladder at post mortem with fixa-
tive (Bouin'ssolution), thento bisectthe organinthesaggitalplane andto examine
the interior with a hand lens or dissecting microscope. By this means tumours
could be detected not infrequently. The two halves of the bladder were then
embedded on the cut surface. As the work progressed and it was found that
tumours did not occur on the suture line of the dome, this portion was cut away
before embedding took place (Fig. 5), as cutting the silk sutures tended to tear the
sections.
The results of such implantations are shown in Fig. 1 to 4. Experience has
shown that epithelial hyperplasia is to be expected even following the implan-
tation ofan innocuous pellet such as paraffin wax and therefore this change is not
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FIG. 1.-Results ofimplantation ofpellets containing 2-naphthylamine in 8 mice which survived for
20 weeks or longer and did not develop tumours. M = metaplasia.
recorded in the charts. Such hyperplasia tends to reach a maximum between
12 and 20 weeks and to subside in the later stages ofthe experiment (Fig. 6 and 7).
Complications such as leakage of urine, infection of the urinary tract, formation
of concretions and blocking of the urethra by the pellet occur. It has not been
possible to estimate the mortality from these causes with any degree of accuracy
owing to an outbreak of ectromelia, but in spite of this, sufficient mice have sur-
vived for 25 weeks or longer to show that the method is practicable and valuable.
2-Naphthylamine.-The purified chemical (Bonser, 1943) was used. In 8 mice,
one surviving for 22 weeks and 7 surviving from 33 to 39 weeks, no tumours
were seen (Fig. 1 and 9). In Mouse 96 (33 weeks) there was generalised epithelial
hyperplasia and a localised area of squamous metaplasia high up on the wall of
the bladder.
2-Amino-l-naphthol hydrochloride.-The chemical was synthesised as described
by Bonser et al. (1951), except in the case of the pellets introduced into Mice 256,
109 and 292, when it was extracted from the urine of a dog fed with 2-naphthyla-
mine (in vivo material). Six mice survived from 22 to 28 weeks, and no tumours
wereseen(Fig. 2). Of 8micewhichsurvivedfrom 30to 39weeks, theepithelium was
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normal in one (33 weeks); one showed extensive squamous metaplasia at 35
weeks (Mouse 23); in one there was an adenoma at 30weeks (Mouse 109); and in
the remaining 5 mice, carcinomas, 4 of which had progressed to the invasion of
muscle, were found (Fig. 12 to 15). In 3 ofthesemicepapillomas were also present
andin2metaplasias, that inMouse 76beingofsquamousandmucous type (Fig. 11).
Paraffin wax.-In this control series standard-sized pellets were made from
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FIG. 2.-Results of implantation of pellets containing 2-amino-1-naphthol hydrochloride in
12 mice which survived for 20 weeks or longer. M -= metaplasia; P = papilloma or ade-
noma; C = carcinoma; 80° = pellet made of wax M.P. 80°; + = in vivo material.
wax only, except in the case of Mice 85 and 86, when 10 to 15 per cent of am-
monium chloride was incorporated in the pellets. Seven mice survived 21 to 30
weeks and 5 mice 30to 39weeks (Fig. 3). No tumours ormetaplasia were observed
(Fig. 8).
3:4:5:6:Dibenzcarbazole.-It was suggested by Armstrong and Bonser (1950)
that wherever this compound could be brought into contact with the tissues in
adequate concentration, carcinogenic action might be anticipated. It was there-
fore decided to test a sample kindly supplied by Professor E. Boyland of the
Chester Beatty Research Institute, Royal Cancer Hospital, London. Eight mice
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survived for 14 weeks or longer (Fig. 4). The first papilloma appeared at 14
weeks, which was earlier by 16 weeks than any tumour caused by 2-amino-1-
naphthol hydrochloride. The first carcinoma occurred at 17 weeks (Fig. 16 and
17). This was earlier by 14 weeks than the first 2-amino-1-naphthol carcinoma
and by 8 weeks than the methylcholanthrene-induced tumour described by Jull
(1951). Squamous metaplasia was a marked feature in 5 mice.
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FIG. 3.-Results of implantation of paraffin wax pellets in 12 mice which survived for 20
weeks or longer and did not develop tumours. 80° = pellet made of wax M.P. 80°; * =
NH4C1 in pellet.
Experiment 2.
Feeding of mice, rats and rabbits.
(a) 2-Naphthylamine by stomach-tube to IF mice fed on a mixed diet, each
mouse weighing on an average 25 g. (Table I): The maximum tolerated dose was
given and treatment was continued until the mice died. The only pathological
change attributable to thechemical was extensive but somewhat focalproliferation
TABLE I.-Administration by Stomach-tube to IF Mice of 5 mg. 2-Naphthylamine
in Arachis Oil (twice weekly) -_ 400 rmg. per kg. Body-weight per week.
Total mice. Weeks of treatment. Cholangiomas.
F.
2-naphthylamine . 12 ]
Arachis oil . . 5
1I. 30-39. 40-49. 50-59. 60-72.
0 0 2 8 13 .8 5 9
6
0 6 0 0
' 7~~~~ 4
f-- --
F. M. %.
5 5 40.0
0 0 0
Numerator = mice with cholangiomas. Denominator = mice dying within the period stated.
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ofthe small intrahepatic bile ducts, associated with mild portal cirrhosis (Fig. 18).
This was termed "cholangioma" by Cook, Hewett, Kennaway and Kennaway
(1940), denoting a proliferative process which may proceed to neoplasia. This
change was not observed in 11 control mice which died before the end ofthe 59th
week nor in breeding mice ofthe same strain observed for many years.
(b) 2-Naphthylamine by stomach-tube to CBA mice fed on a mixed diet, each
mouse weighing on an average 30 to 35 g. (Table II): Again the only pathological
changes were in the liver. Half of the experimental mice which survived for 50
weeks developed hepatomas, which were regarded as true tumours. Many grew
to a large size, and became pedunculated and then infarcted. Two tumours were
histologically malignant. Hepatomas did not occur in a small group of control
mice surviving as long as the experimental animals, but benign tumours were
present in control breeding mice to the extent of8.1 per cent (TableII). Although
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FIG. 4.-Results ofimplantation ofpellets containing 3:4:5:6-dibenzcarbazole in 8 mice which
survived for 14 weeks or longer. M = metaplasia; P = papilloma or adenoma; C =
carcinoma.
Andervont (1950), has pointed out that variations in incidence of hepatomas
must be regarded with caution, this difference would appear to be biologically
as well as statistically significant.
TABLE II.-Administration by Stomach-tube to CBA Mice of 5 mg. 2-Naphthyla-
mine in Arachis Oil (twice weekly) 240 mg. per kg. body-weightper week.
Total mice. Weeks of treatment. Hepatomas.
F. M. 30-39. 40-49. 50-59. 60-69. 70-89. F. M. %.
2-naphthylamine . 14 9 . 0 1 2 10 7 6 520 ' ~~~2 4 3 1-4 2 ~~~~~~~. 7 6 '52.0
0 0 Arachis oil 77. 20 0 * .0 0 0
-0-~ ~ ~ 0 0 7
Breeding . . 102 46 . 0 0 20 72 7 16 4-0 20 72 758K
* Single cholangioma.
Numerator = mice with hepatomas. Denominator = mice dying within the period stated.CARCINOGENIC PROPERTIES OF 2-NAPHTHYLAMINE
(c) 2-Naphthylamine by incorporation in the diet of CBA mice: The basic
diet consisted ofcasein (20 per cent), starch (50per cent), arachis oil (10 per cent),
yeast (10 per cent), vitamin oil, salts and water to make a paste. The chemical
was dissolved in arachis oil and well mixed with the diet. Modifications of the
diet were also arranged so that the fat content was high (30 per cent arachis oil),
excess of cystine was added (0.5 percent) or the protein content was reduced (10
per cent casein) and cystine added (0-5 per cent). The amount ofthe diet eaten
on an average by each mouse was weighed, and it was found that only 160 mg.
ofchemical per kg. ofbody weight was ingested compared with 240 to 400 mg. by
stomach tube (Tables I, II and III). Hepatomas occurred in each group (Table
III), the variations in incidence not being significant. Malignant hepatomas were
found in 16 mice, one having metastasised to the lungs.
TABLE III.-Feeding of CBA Mice with 2-Naphthylamine in Adequate Synthetic
Diet - approx. 160 mg. per kg. body-weight per week.
Total mice. Weeks of treatment. Hepatomas.
Diet. , ~ r A - _
F. M. 40-49. 50-59. 60-69. 70-79. 80-89. F. M. %.
Basic . . . 12 14 . 0 1 2 8 5 6 42- 3
(20%° protein) 1 2 20
1 13' High fat . . 12 14 . 0 3 0 0 3 9 5 53-6 23 (30%) 0 1 3 0
Highcystine 15 14 1 1 3 24 0 4 9 48-0
(0.5%) I 1 8 1 ~ 43~
Low protein . . 15 15 . 2 3 0 24 1 7 4 36- 7
(10%) ±
High cystine
(0.5%)
* Metastasis to the lungs in one mouse.
Numerator - mice with hepatomas. Denominator = mice dying within the period stated.
(d) 2-Naphthylamine by incorporation in the diet of rats: Albino rats were
supplied by Glaxo Ltd. and were three-quarters grown. The basic diet consisted
of casein (10 per cent), starch (80 per cent), arachis oil (5 per cent), yeast (2.5
per cent), vitamin oil and salts. To this was added 2-naphthylamine (0-1 g. per
kg.) and water to make a stiff dough. From Table IV it is seen that 4 papillomas
of the bladder occurred among 31 rats which survived treatment for 60 weeks or
more; no tumours occurred in the controls. Reduction in the protein content
ofthe diet may have played some part in the appearance of the tumours but the
numbers are too small to draw any firm conclusion. Hyperplasia of the bladder
epithelium was seen in 6 treated and 5 control rats, and squamous metaplasia in
3 and 5 rats respectively. The nematode Trichosomoides crasaicauda was seen in
the bladder epithelium or free in the lumen of 7 control rats but not in treated
animals. No cellular reaction was seen in relation to them, which was the ex-
perience ofSpitz, Maguigan and Dobriner (1950). The liver changes were ofvery
mild type. Twenty-three experimental rats showed mild portal cirrhosis, com-
pared with 16 control rats. Sixteen experimental rats showed mild bile-duct pro-
liferation compared with 7 control rats. One experimental rat had a well-
developed cholangioma and 2 control rats had hepatomas. Thus, while it would
seem that there was rather more cirrhosis and bile-duct proliferation in the
treated group, these changes were also present in the control group. Two-thirds
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ofthe rats in bothexperimental and control groups showedhyperplasia andhyper-
keratosis of the forestomach epithelium; one-third of both groups had keratinis-
ing squamous papillomas of the forestomach.
(e) 2-Naphthylamine by spoon to rabbits: Three male and 3 female rabbits
were fed on a mixed diet of oats, hay and mangels or green food according to the
season. Twice per week 200 mg. ofpowdered 2-naphthylamine was given orally
by means of a spoon. The animals maintained their weight satisfactorily and
were killed when it appeared that they would not survive longer (Table V). The
epithelial changes in the bladder were of a minor order. In Rabbit 12 there was
a tiny transitional-cell benign papilloma at 43 years (Fig. 19); in Rabbit 8 there
was epithelial hyperplasia with early downgrowth simulating an adenoma at
5- years.
EXPLANATION OF PLATES.
FIG. 5.-Bladder of Mouse 82, 2-amino-1-naphthol hydrochloride pellet for 39 weeks. The
bladder is viewed from above, after cutting away the dome. The dilated urethral orifice
is seen as a dark circle above the centre. Immediately adjacent are 2 small papillomata.
To the left and right are projecting tumours. X 4.
FIG. 6.-Bladder wall of Mouse 84, 2-amino-1-naphthol hydrochloride pellet for 4i weeks,
showing simple hyperplasia. x 35.
FIG. 7.-Bladder wall of Mouse 119, paraffin wax pellet for 21 weeks, showing urethral orifice.
There is marked epithelial hyperplasia, accentuated by tangential cutting. This is the most
advanced change seen in any mouse of this group. X 30.
FIG. 8.-Bladder of Mouse 85, ammonium chloride in paraffin wax pellet for 37 weeks. Wall
nearly normal. x 6.
FIG. 9.-Bladder of Mouse 91, 2-naphthylamine pellet for 34 weeks. Wall nearly normal.
The dilated ureter is seen at bottom right. x 6.
FIG. 10.-Bladder wall of Mouse 96, 2-naphthylamine pelletfor 33 weeks. Localisedpatch of
epithelial hyperplasia close to dilated urethral orifice. X 45.
FIG. 11.-Bladder wall ofMouse 76, 2-amino-1-naphthol hydrochloride (synthetic) pellet for 34
weeks. Squamous metaplasia on left and mucous metaplasia on right. The mucus stained
red with muci-carmine. X 60.
FIG. 12.-Bladder wall of Mouse 109, 2-amino-1-naphthol hydrochloride (in vivo) pellet for
30 weeks. Adenoma with commencing downgrowth but no invasion of muscle. x 130.
FIG. 13.-Bladder wall of Mouse 81, 2-amino-1-naphthol hydrochloride (synthetic) pellet for
38 weeks. Transitional-cell papilloma, just invading muscle on left. x 60.
FIG. 14.-Bladder wall of Mouse 82, 2-amino-1-naphthol hydrochloride (synthetic) pellet for
39 weeks. Transitional-cell carcinoma with downgrowth in central portion. X 20.
FIG. 15.-Bladder wall ofMouse 24, 2-amino-1-naphthol hydrochloride (synthetic) pellet for 31
weeks. Transitional-cell carcinoma invading the muscular wall of the bladder as far as the
epithelium ofthe dilated ureter. A narrowband ofmuscle still remains on the right. X 50.
FIG. 16.-Bladder wall of Mouse 126, 3:4:5:6-dibenzcarbazole pellet for 14 weeks. Tran-
sitional cell papilloma. X 50.
FIG. 17.-Bladder of Mouse 175, 3:4:5:6-dibenzcarbazole pellet for 17 weeks. The lower half
of the bladder is filled with cancer, while the upper part is partially contracted. Some
suture material is visible top right. The uterus is seen posterior to the bladder. x 6.
FIG. 18.-IF female mouse, receiving 2-naphthylamine by stomach-tube for 72 weeks.
Multiple cholangiomatous areas. X 85.
FIG. 19.-Male Rabbit 12, fed with 2-naphthylamine for 41 years. Transitional cell papilloma
at the dome, with slight hyperplasia of adjacent epithelium. x 30.BRITISH JOURNAL OF CANCER.
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TABLE V.-Oral Administration of 2-Naphthylamine to Rabbits - 100 mg. per kg.
body-weight per week.
Approximate
Period of total dose of
No. Colour. Sex. treatment chemical Changes in bladder.
(years). administered
(g.)
7 . Black . Female . 21 . 58 . Normal.
9. . . 4 . 84 .
12 . Chinchilla . Male . 41 . 100 . Transitional cell papilloma.
11 . ,, . Female . 5¼ . 110 . Normal.
10 .. . Male . 5¼ . 110 . ,,
8 . Wild . . 5¼ . 110 . Epithelial hyperplasia with
downgrowth.
Experiment 3.
Subcutaneous injection of mice and rats.
(a) 2-Amino-l-naphthol hydrochloride in RIII and stock mice: A fresh suspen-
sion of the synthetic chemical was made in arachis oil, and each mouse was in-
jected subcutaneously in the flank once per fortnight with 5 mg. per 100 g. body
weight. Great difficulty was experienced in finding the maximum tolerated dose
and even this amount caused ulceration of the skin on occasion. Twenty-three
mice survivedfor 40 weeks and 3 subcutaneousspindle-cell sarcomas were observed
at the site ofinjection (Table VI). Other-lesions such as hepatoma and leukaemia
were observed, but these conditions have also been seen in untreated mice and
are not necessarily attributable to the treatment. The bladders were normal.
(b) 2-Amino-l-naphthol hydrochloride in albino rats, derived from the Glaxo
stock: Subcutaneous injections were made as in the mice. Fourteen rats sur-
vived to the tumour period and 5 subcutaneous spindle-cell sarcomas were ob-
served at the site of injection (Table VI). All these tumours invaded underlying
voluntary muscle and one invaded also the pleural and peritoneal cavities. There
were metastases in the lungs from one tumour.
TABLE VI.-Subcutaneous Injection of Mice and Rats with 2-Amino-l-naphthol
Hydrochloride in Arachis Oil (5 mg. per 100 gm. body-weightperfortnight.)
No. Survival (weeks).
Animal. A Weeks of Type of ,- Total.
F treatment. lesion. 449. 559. 669.
over incidence. M. F. 40-49. 50-59. 6ov9. 70 70.
Stock .6 9 . 65 . Subcutaneous 1 0 0 2
mice sarcoma 0 3 5 7
Hepatoma 0 1 3 0 4 0 3 5 7
Leukaemia . 0 3 7 . 3
RIII . 4 4 . 29 . Subcutaneous 0 1 0 0 1
mxice sarcoma 30 0 2 0
Leukaemia . 0 1 0 1 3 1 2 21
Stock .8 6. Until . Subcutaneous . 1 3 1 5
rats death sarcoma
* = 6 rats still alive after 80 weeks of treatment.
Numerator = number of animals showing the lesion. Denominator number of animals
dying within the period stated.CARCINOGENIC PROPERTIES OF 2-NAPHTHYLAMINE
Experiment 4.
Painting of mice.
2-Naphthylamine in IF mice: A saturated solution ofthe chemical in benzene
was painted on the skin between the shoulder-blades once per week. In spite of
a satisfactory survival rate (Table VII) no tumours of the skin nor liver occurred.
TABLE VII.-Painting ofSkin of IF Mice with Saturated Solution of 2-Naphthyla-
mine in Benzene.
Total mice. Weeks of treatment. Tours Tumours * Turnours Turnours
A~ -9 5 S.ofskin. ofliver. F. M. 40-49. 50-59. 60-99.
9 16 . 7 3 15 . 0 . 0
DISCUISSION.
There is no certain knowledge of the mode of entry of 2-naphthylamine into
workers in the chemical industry. Three routes may be involved-ingestion, in-
halation, and absorption through the skin. Therefore, after the discovery by
Hueper and his colleagues in 1938 (Hueper, 1938; Hueper, Wiley and Wolfe,
1938) that bladder cancer could be induced in dogs by feeding the chemical, this
method was chosen for testing smaller domestic animals with a view to avoiding
the expense and other difficulties inherent in treating dogs. When it had been
shown by Bonser, Clayson and Jull (1951) that the metabolite of2-naphthylamine
present in greatest quantity in the urine of the dog after feeding was 2-amino-1-
naphthy] sulphuric acid (II), it was necessary to reconsider the mode of exhibition
of the various substances inthe light of their chemical properties. 2-Naphthyla-
mine base is a relatively stable compound, is oil and benzene-soluble, and can be
used for feeding, injection or painting. 2-Amino-l-naphthol hydrochloride is an
unstable compound, which is easily oxidised, and is water-soluble. Moreover,
from the results of metabolism and biological experiments in various species
(Bonser, Clayson and Jull, 1951) it seemed probable that to act as a carcinogen
it would require to be present at a certain levelof concentration. This contention
would be greatly strengthened should the cat prove to be a susceptible animal.
It was for these reasons that the idea ofintroducing thecompound incorporated
in a solid vehicle into the lumen of the mouse bladder was explored (Jull, 1951).
It was postulated that a high diffusion rate could be expected, that conditions
inside the bladder would tend to be anaerobic, and that the exposure of the
epithelium to the carcinogen would be almost continuous. In addition, inter-
mediary metabolism by the liver would be eliminated.
The results of Experiment 1 are regarded as sound evidence that 2-amino-1-
naphthol hydrochloride is a local carcinogen, whereas 2-naphthylamine is not.
This statement is supported by the fact that bladders implanted with paraffin
wax remained free from tumours, whereas in bladders implanted with the known
carcinogens 20-methylcholanthrene (Jull, 1951) and 3:4:5:6-dibenzcarbazole
tumours occurred well within the experimental period of the negative results
(Fig. 1 to 4). The induction of tumours by the local action of the metabolite
of2-naphthylamine shows also that there is nofactorinherent inthe mouse bladder
which precludes the development of tumours in this form of carcinogenesis.
Additional evidence for the carcinogenic activity of2-amino-1-naphthol hydro-
chloride has been obtained. A few local sarcomas have occurred in mice and rats
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following subcutaneous injections in oil (Table VI). Those obtainedin mice would
seem to have significance, as although many subcutaneous injections of the same
oil containing oestrogens and other chemicals have been made into mice in this
laboratory, no sarcomas have hitherto been observed. The 5 sarcomas in rats
are probably ofless significance, as the subcutaneous tissues of this species are so
singularly reactive to foreign materials of any kind. In 1938 Hueper obtained 3
retothelial sarcomas in mice by intraperitoneal injection of impure 2-amino-1-
naphthol in stock mice (Hueper, 1938).
By contrast, no evidence has yet been brought forward to suggest that pure
2-naphthylamine is locally carcinogenic, though our own results of subcutaneous
injection in oily solution into mice are not yet ready. The few sarcomas induced
by Hackmann (1951) followed the use of the impure technical compound. 2-
Naphthylamine does, however, induce distant tumours in mice, in the form of
hepatomas inthe CBAandcholangiomas inthe IF strains. It is suggested that the
metabolite is actinglocallyonthelivercells. Localtumours have not been observed
following thefeeding ofdogs, mice, rats andrabbits. Nor did Rhoads (quoted by
Hartwell, 1951), in a large experiment, find tumours elsewhere than in the bladder
in the rat. No tumours occurred in mice after painting a benzene solution on the
skin (TableVI). In general, aromatic amines are not locally carcinogenic, though
there are notable exceptions, such as 2-anthramine (Bielschowsky, 1946), and the
amino-stilbenes (Haddow, Harris, Kon and Roe, 1948).
Taking all the above evidence into consideration the case is very strong for
accepting 2-amino-1-naphthol or its conjugates as the active carcinogen formed by
the metabolism of 2-naphthylamine in man and the dog. It seems worthy of
emphasis that such a conclusion would scarcely have been possible without the
positive evidence obtained by the direct introduction of the test substances into
the mouse bladder. This experiment indicates that it is the metabolite which is
carcinogenic and not animpurity present in the 2-naphthylamine, as was suggested
many years ago and has recently been re-emphasised by Case and Pearson (1952).
The 2-naphthylamine used for the implantations was from the same batch as that
used for the feeding and painting experiments. The 2-amino-1-naphthol was
synthesised in this laboratory by sodium dithionate reduction of 2-nitroso-1-
naphthol, and it seems unlikely that either 2:2-dinaphthylamine or 3:4:5:6-di-
benzcarbazole and pyrene, suggested as impurities in 2-naphthylamine by Case
and Pearson (1952), would be present in this substance. Moreover, when 2 per
cent 20-methylcholanthrene in paraffin wax was implanted into the mouse
bladder (Jull, 1951) no tumours were obtained in 4 mice surviving from 21 to
42 weeks. This concentration of carcinogen is very much greater than that sug-
gested for the possible impurities of 2-naphthylamine.
There is no evidence to differentiate between the direct action of 2-amino-1-
naphthyl sulphuric acid on the bladder epithelium or its further chemical trans-
formation in the bladder. Such chemical transformation might take the form of
hydrolysis to give 2-amino-1-naphthol or the formation of polycyclic or other
molecules.
An important observation in both the industrial and experimental diseases
is the location of the tumours in the bladder and not in the rest of the urinary
tract. The rate of excretion of a dose of2-naphthylamine administered orally to
the dog was shown toreacha peakapproximately4 hourslater, (unpublished obser-
vation). Thus it is probable that urine containing an effective level ofthe meta-CARCINOGENIC PROPERTIES OF 2-NAPHTHYLAMINE 423
bolite passes down the renal tubules, pelvis and ureter for a period of about 4
hours, whereas urine stored in the bladder before, during and after the peak may
contain an effective level for a longer period. Some other mechanism may also
be involved, as when 2-amino-fluorene was fed to rabbits, ureteric as well as
vesical tumours were obtained (Bonser and Green, 1950).
2-Amino-l-naphthol is an ortho-hydroxyamine and the hypothesis is being
examined that other carcinogenic aromatic amines are active by virtue of their
conversion in the body to compounds of this type. In preliminary experiments,
using an impure sample of 1-amino-2-naphthol hydrochloride, supplied by The
British Drug Houses Ltd., evidence of carcinogenic activity has been obtained in
5 out of 6 mice by the bladder implantation method (unpublished observation).
Walpole, Williams and Roberts (1952) are pursuing similar ideas in the 4-aminodi-
phenyl series.
The evidence which has been brought forward here to show that a metabolite
of 2-naphthylamine is carcinogenic supports the case for a more vigorous pursuit
of metabolites from other chemicals which may be taken into the human body.
The types ofsubstance which immediately come to mind are the aromatic amines
and some ofthose chemicals which are so liberally used as food-colouring matters
at the present time. Further, knowledge about the metabolic changes which take
place in other groups of chemicals, while not having immediate practical applica-
tion as far as industry is concerned, might enable an opinion to be expressed as to
whether it would be safe to introduce new types of chemical into industrial or
other processes before the damage is actually done.
SUMMARY.
Preliminary experiments had suggested that 2-amino-1-naphthol hyvdro-
chloride was a local carcinogen when introduced directly into the lumen of the
mousebladder (Bonser, Clayson andJull, 1951). Furtherexperiments have shown
that this method is practicable on a larger scale. Metaplasia, papilloma and car-
cinoma were induced when 2-amino-l-naphthol hydrochloride and 3:4:5:6-di-
benzcarbazole were tested, but no tumours were obtained with 2-naphthylamine
nor paraffin wax (Fig. 1 to 4).
Additional evidence of the carcinogenic properties of 2-amino-l-naphthol
hydrochloride was obtained by the occurrence of a few sarcomas in mice and rats
following subcutaneous injection in oil (Table VI).
No local tumours occurred when 2-naphthylamine was administered orally to
mice, rats and rabbits. Hepatomas occurred in mice, which suggested that the
metabolite was acting locally on the liver cells. A few benign bladder tumours
occurred in rats and rabbits at a late date in the experiments (Tables IV and V).
This investigation has been supported by a grant from the Association of
British Chemical Manufacturers. We are indebted to Dr. L. H. Stickland and to
Dr. E. C. Armstrong for help in carrying out some of the mouse experiments.
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